April 17, 2026 · Prehospital emergency care · DOI: 10.1080/10903127.2026.2658592

Intranasal Versus Intramuscular Midazolam in Pediatric Seizure Control: A Systematic Review and Meta-Analysis

Listen to this summary

The authors aimed to determine whether intranasal (IN) or intramuscular (IM) administration of midazolam is more effective for rapid seizure control in pediatric patients, particularly in prehospital settings where intravenous access is not available. Their meta-analysis of five studies involving 3,933 patients found that IM midazolam resulted in quicker seizure termination and a lower need for rescue therapy compared to IN midazolam. Consequently, IM midazolam is suggested as a preferable first-line treatment for acute seizures in these scenarios.

Jonathan D Mohnkern, Ayesha Khalid, Marwa Ibrahim, Vedanti Dave, Pietra Peterlini Chierighini, Alexandra Salazar Riaño, Tolu Ajibade, Thaís S Martins Shehan

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play